MedTrace Logo

Multicenter Normal Reference Study of Tissue Motion Tracking of Mitral Annular Displacement(TMAD)

NCT04399447 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2400

Last updated 2020-05-22

No results posted yet for this study

Summary

To establish the range of TMADmid、TMADmidpt% by using tissue motion tracking of mitral annular displacement (TMAD), and to explore the influencing factors.

Conditions

  • Left Ventricular Systolic Dysfunction
  • Healthy Volunteers

Interventions

RADIATION

Echocardiography

left ventricular systolic function of all participants were measured by tissue motion tracking of mitral annular displacement using PHILIPS

Sponsors & Collaborators

  • Weidong Ren

    lead OTHER

Principal Investigators

  • Weidong Ren · Shengjing Hospital of China Medical Univeristy

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-30
Primary Completion
2021-06-30
Completion
2021-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04399447 on ClinicalTrials.gov